LYDOLYTE Trademark

Trademark Overview

On Monday, March 7, 2022, a trademark application was filed for LYDOLYTE with the United States Patent and Trademark Office. The USPTO has given the LYDOLYTE trademark a serial number of 97299852. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, May 13, 2025. This trademark is owned by MEDRX CO., LTD.. The LYDOLYTE trademark is filed in the Pharmaceutical Products category with the following description:

Lidocaine in the form of patches and preparations

General Information

Serial Number97299852
Word MarkLYDOLYTE
Filing DateMonday, March 7, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, May 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and ServicesLidocaine in the form of patches and preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 14, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMEDRX CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKagawa 769-2712
JP
Party NameMEDRX CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKagawa 769-2712
JP

Trademark Events

Event DateEvent Description
Thursday, March 10, 2022NEW APPLICATION ENTERED
Friday, March 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 16, 2022ASSIGNED TO EXAMINER
Monday, January 9, 2023NON-FINAL ACTION WRITTEN
Monday, January 9, 2023NON-FINAL ACTION E-MAILED
Monday, January 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 14, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 14, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, March 14, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 14, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, March 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 1, 2023SOU EXTENSION 1 FILED
Wednesday, November 1, 2023SOU EXTENSION 1 GRANTED
Friday, November 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 17, 2024SOU EXTENSION 2 FILED
Friday, May 17, 2024SOU EXTENSION 2 GRANTED
Friday, May 17, 2024SOU TEAS EXTENSION RECEIVED
Saturday, May 18, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2024SOU EXTENSION 3 FILED
Friday, November 1, 2024SOU EXTENSION 3 GRANTED
Tuesday, May 13, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, May 13, 2025SOU EXTENSION 4 FILED
Tuesday, May 13, 2025SOU EXTENSION 4 GRANTED
Wednesday, May 14, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 1, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

lydolyte preparations patches form lidocaine